Drug Profile
Morphine inhalation - Sheffield Pharmaceuticals
Latest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Sheffield Pharmaceuticals
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer pain
Most Recent Events
- 17 Jun 2003 Sheffield Pharmaceuticals has filed for protection under Chapter 7 bankruptcy laws
- 17 Jun 2003 Discontinued - Clinical-Phase-Unknown for Cancer pain in United Kingdom (Inhalation)
- 15 Oct 2002 Sheffield regained intellectual property rights to Premaire-Morphine